An Acute Human Intervention With Flavonoid to Investigate Absorption, Metabolism and Excretion
COB
An Acute Flavonoid Intervention Study to Examine Influences of Genotype and Phenotype on Flavonoid Absorption, Metabolism and Excretion
1 other identifier
interventional
240
1 country
1
Brief Summary
The era of general dietary recommendations for the whole population may be coming to an end, as it is becoming apparent that we are all unique and do not respond in the same way to the same foods. Within a decade it is believed that doctors will be able to take profiles of their patients, identify specific diseases for which they are at risk and create personalised nutrition plans accordingly. At the University of East Anglia, UK the investigators are interested in particular food compounds known as flavonoids which can be found in foods such as chocolate, orange juice and blackberries (COB). The study will determine if factors such as age, gender, genetics and the bacteria present in our guts contribute to variability between individuals in their absorption, metabolism and excretion of flavonoids.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 20, 2013
CompletedStudy Start
First participant enrolled
July 1, 2013
CompletedFirst Posted
Study publicly available on registry
August 14, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedAugust 14, 2013
August 1, 2013
10 months
June 20, 2013
August 12, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Flavanoid metabolites
Concentrations of flavonoid metabolites will be assessed using state-of-the-art liquid chromatography-tandem mass spectrometry (LC-MS/MS) and quantified against commercially available standards. Serum and urine will be acidified and then extracted by solid phase extraction (SPE). Metabolite identification will be performed using a QTrap 4000 linear ion trap mass spectrometer (ABSciex, Canada) by multi-reaction monitoring (MRM) optimized for the detection of pure standards. Metabolites will be confirmed on the basis of retention time and parent-daughter ion fragmentation transitions.
12 months
Genes involved in flavonoid metabolism
Candidate genes encoding proteins involved in the flavonoid metabolism pathway will be identified from the literature and available pathway databases such as gene ontology, gene network, KEGG. Putative functional SNPs within these genes will be identified from the literature and/or online tools such genepipe and polyphen. In addition tag SNPs will be identified across the selected genes. This approach will involve the genotyping of approximately 200 single nucleotide polymorphisms (SNPs). Genotyping of these SNPs will be performed with the MassARRAY and iPlex systems of the Sequenom genotyping platform (Sequenom, San Diego, CA), which uses the MALDITOF primer extension assay. The associations of these SNPs and flavonoid metabolism will them be investigated.
12 months
Secondary Outcomes (1)
Effect of gut microbiota on flavonoid metabolism
18 months
Study Arms (1)
COB mixture
EXPERIMENTALOne time ingestion of flavonoid mixture from chocolate (80 g), orange juice (500 ml)and blackberries (160 g), also known as the 'COB mixture' providing approximately 640 mg of flavan-3-ols, 390 mg of anthocyanins and 342 mg of flavanones respectively.
Interventions
Eligibility Criteria
You may qualify if:
- Male or Female
- Caucasian of European origin
- Age either between 18-30 years or between 65-77 years
You may not qualify if:
- BMI \< 18.5 kg/m2 or BMI \> 30 kg/m2
- Smokers or nicotine users
- High (above 140/90 mmHg ) or low (less than 90/60 mmHg) blood pressure
- Having any existing medical conditions or significant past medical history likely to affect study measurements e.g., type 2 diabetes, cardiovascular, renal, liver or gastrointestinal diseases
- Unsatisfactory biochemical, haematological or urinary assessment, indicating abnormal; renal or liver function, full blood profile, impaired glucose handling, deranged lipids or measurements considered to be counter indicative of the study by the clinical advisor
- Taking any prescribed medication that could interact with the enzymes involved in the metabolism of flavonoids
- Taking flavonoid containing supplements or other dietary supplements for one month prior to the study (and duration of the study intervention)
- Known allergies to the intervention foods
- Consume more alcoholic beverages on average than 21 units/wk for men, or 14 units/wk for women (The UK Department of Health recommendations)
- Pregnant, breast feeding, or planning a pregnancy (or having fertility treatment)
- Unable to provide informed consent to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of East Anglialead
- Fred Hutchinson Cancer Centercollaborator
- University of Washingtoncollaborator
Study Sites (1)
Department of Nutrition, University of East Anglia
Norwich, Norfolk, NR4 7TJ, United Kingdom
Related Publications (1)
Kay CD, Tejera N, Jennings A, Haldar S, Diment BC, Bevan D, Crossman LC, Li S, Cassidy A, Minihane AM. Effect of age and sex on the urinary elimination of a single dose of mixed flavonoids: results from a single-arm intervention in healthy United Kingdom adults. Am J Clin Nutr. 2025 Jul;122(1):101-111. doi: 10.1016/j.ajcnut.2025.05.006. Epub 2025 May 12.
PMID: 40368267DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne-Marie Minihane, PhD
Department of Nutrition, University of East Anglia, Norwich, U.K.
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 20, 2013
First Posted
August 14, 2013
Study Start
July 1, 2013
Primary Completion
May 1, 2014
Study Completion
September 1, 2014
Last Updated
August 14, 2013
Record last verified: 2013-08